Hilltop Holdings Boosts Amgen Stock Position

Institutional investor increased stake in medical research company by over 700%

Mar. 16, 2026 at 11:07am

Got story updates? Submit your updates here. ›

Hilltop Holdings Inc., an institutional investor, significantly increased its position in Amgen Inc. (NASDAQ:AMGN) during the third quarter, according to a recent SEC filing. The company boosted its Amgen holdings by 715.8%, now owning 29,524 shares worth approximately $8.3 million.

Why it matters

This move by Hilltop Holdings suggests the institutional investor sees strong potential in Amgen's future performance. As a major player in the biotechnology and pharmaceutical industry, Amgen's stock movements and investor activity are closely watched by analysts and the broader market.

The details

According to the filing, Hilltop Holdings purchased an additional 25,905 shares of Amgen during the third quarter, bringing its total position to 29,524 shares. This represents a significant 715.8% increase in the institutional investor's stake in the medical research company.

  • Hilltop Holdings increased its Amgen position during the third quarter of the year.

The players

Hilltop Holdings Inc.

An institutional investor that significantly increased its stake in Amgen Inc. during the third quarter.

Amgen Inc.

A global biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics to address serious illnesses.

Got photos? Submit your photos here. ›

The takeaway

Hilltop Holdings' substantial increase in its Amgen position suggests the institutional investor has a positive outlook on the biotechnology company's future prospects. This type of significant investor activity is closely watched by the broader market as it can signal potential opportunities or risks for Amgen's stock performance.